Guyasuta Investment Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Hold
10,767
0.09% 104
2026
Q1
$1.64M Hold
10,767
0.1% 99
2025
Q4
$1.48M Hold
10,767
0.08% 106
2025
Q3
$1.38M Hold
10,767
0.08% 104
2025
Q2
$1.3M Buy
10,767
+313
+3% +$35.3K 0.08% 102
2025
Q1
$1.17M Sell
10,454
-100
-0.9% -$10.6K 0.08% 105
2024
Q4
$1.03M Sell
10,554
-101
-0.9% -$10.8K 0.06% 113
2024
Q3
$1.23M Sell
10,655
-1,918
-15% -$218K 0.08% 102
2024
Q2
$1.27M Sell
12,573
-101
-0.8% -$10.1K 0.09% 97
2024
Q1
$1.28M Hold
12,674
0.09% 97
2023
Q4
$1.28M Sell
12,674
-4,127
-25% -$398K 0.09% 97
2023
Q3
$1.71M Sell
16,801
-116,388
-87% -$11.8M 0.13% 75
2023
Q2
$13.4M Sell
133,189
-4,390
-3% -$439K 0.99% 31
2023
Q1
$12.7M Buy
137,579
+385
+0.3% +$33.6K 0.98% 33
2022
Q4
$12.4M Sell
137,194
-114
-0.1% -$9.6K 0.98% 31
2022
Q3
$10.4M Buy
137,308
+1,194
+0.9% +$99K 0.9% 32
2022
Q2
$11.5M Sell
136,114
-297
-0.2% -$26.1K 0.9% 32
2022
Q1
$12M Sell
136,411
-1,575
-1% -$136K 0.82% 34
2021
Q4
$12.1M Sell
137,986
-1,291
-0.9% -$107K 0.79% 34
2021
Q3
$11.4M Buy
139,277
+601
+0.4% +$54.1K 0.81% 34
2021
Q2
$12.7M Sell
138,676
-292
-0.2% -$26K 0.91% 34
2021
Q1
$11.9M Sell
138,968
-3,681
-3% -$330K 0.93% 35
2020
Q4
$13.5M Buy
142,649
+1,335
+0.9% +$117K 1.13% 28
2020
Q3
$12.3M Buy
141,314
+40
+0% +$3.46K 1.14% 27
2020
Q2
$12.3M Buy
141,274
+6,649
+5% +$574K 1.27% 25
2020
Q1
$11.1M Buy
134,625
+117,938
+707% +$10.5M 1.33% 24
2019
Q4
$1.58M Sell
16,687
-45
-0.3% -$4.04K 0.15% 78
2019
Q3
$1.45M Sell
16,732
-1,200
-7% -$108K 0.15% 80
2019
Q2
$1.64M Sell
17,932
-3,197
-15% -$271K 0.17% 75
2019
Q1
$1.82M Sell
21,129
-324
-2% -$26K 0.2% 69
2018
Q4
$1.65M Sell
21,453
-335
-2% -$26.1K 0.2% 66
2018
Q3
$1.68M Buy
21,788
+2,059
+10% +$152K 0.18% 75
2018
Q2
$1.33M Sell
19,729
-613
-3% -$42.3K 0.15% 82
2018
Q1
$1.47M Sell
20,342
-966
-5% -$73.5K 0.17% 77
2017
Q4
$1.6M Sell
21,308
-2,466
-10% -$186K 0.18% 71
2017
Q3
$1.83M Hold
23,774
0.22% 59
2017
Q2
$1.78M Sell
23,774
-1,909
-7% -$135K 0.21% 60
2017
Q1
$1.71M Sell
25,683
-10,928
-30% -$728K 0.21% 61
2016
Q4
$2.39M Sell
36,611
-125,092
-77% -$8.11M 0.31% 47
2016
Q3
$11.4M Buy
161,703
+5,346
+3% +$390K 1.46% 28
2016
Q2
$11.6M Buy
156,357
+24,933
+19% +$1.72M 1.55% 26
2016
Q1
$8.53M Buy
131,424
+126,192
+2,412% +$8.58M 1.19% 29
2015
Q4
$403K Buy
5,232
+73
+1% +$5.8K 0.06% 146
2015
Q3
$424K Buy
5,159
+285
+6% +$25.4K 0.06% 151
2015
Q2
$429K Buy
4,874
+436
+10% +$40K 0.06% 161
2015
Q1
$392K Sell
4,438
-687
-13% -$60.9K 0.05% 159
2014
Q4
$425K Buy
5,125
+740
+17% +$61.3K 0.06% 152
2014
Q3
$369K Sell
4,385
-39
-0.9% -$3.15K 0.05% 156
2014
Q2
$358K Sell
4,424
-39
-0.9% -$3.07K 0.05% 158
2014
Q1
$339K Hold
4,463
0.05% 155
2013
Q4
$321K Hold
4,463
0.05% 155
2013
Q3
$306K Hold
4,463
0.05% 156
2013
Q2
$282K Buy
+4,463
New +$290K 0.05% 154

Other funds holding NVS

Guyasuta Investment Advisors's NVS Position: Q2 2026 in Review

Guyasuta Investment Advisors held its Novartis (NVS) position steady in Q2 2026 at 10,767 shares worth $1.69M. The position accounts for 0.09% of the portfolio, ranked #104.

Guyasuta Investment Advisors first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.5M in Q4 2020. 1,027 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Guyasuta Investment Advisors held 10,767 shares of Novartis worth $1.69M as of Q2 2026.
  • Guyasuta Investment Advisors left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.09% of Guyasuta Investment Advisors's portfolio in Q2 2026, its #104 holding.
  • Guyasuta Investment Advisors first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
  • Guyasuta Investment Advisors's Novartis position peaked at $13.5M in Q4 2020.
  • 1,027 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Guyasuta Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.